Support for starting addiction treatment in community settings
Part of Mental health clinical trials.
This study looks at ways to help people who have just started taking buprenorphine for opioid use disorder stick with their treatment. It tests extra support outside of a clinic to help you stay on track and feel better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older
- You were prescribed buprenorphine for opioid use disorder within the last 90 days
- You can give written permission to be in the study
- You can provide contact information so the study team can reach you
- You speak English well enough to understand the study and complete surveys
- You have not been on medication for opioid use disorder for more than 10 days in a row in the month before starting your current buprenorphine
- You are not currently in jail or prison, and have no legal issues that would stop you from taking part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a peer recovery support program for people starting inpatient treatment for opioid use disorder. It aims to help you stay on medication for opioid use disorder and build a strong recovery.
This study tests extra support to help people who recently started buprenorphine treatment for opioid use disorder stay on track with their recovery, especially if they are new to treatment or recently released from jail or prison.
This study compares two medications, methadone and buprenorphine, to see which helps people stay in treatment for opioid use disorder. You may be eligible if you are starting a new treatment episode.
This study tests a new way to support patients taking buprenorphine-naloxone for opioid addiction. It uses regular check-ins to help you and your doctor stay on track with your treatment.
This trial studies a program meant to improve treatment access and support recovery for people with opioid use disorder who also have mental health symptoms. It may help if you are new to the program or recently relapsed, or if mental health symptoms have worsened—even without a relapse.
This study tests a new way to receive buprenorphine—a once-a-month injection—from a mobile clinic that comes to you. It aims to make treatment more convenient and acceptable for people with opioid use disorder.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.